<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Garner Jonassen | Activity</title>
	<link>https://www.catswannabecats.com/members/ounceturkey75/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/ounceturkey75/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Garner Jonassen.</description>
	<lastBuildDate>Wed, 10 Jun 2026 07:23:50 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">dae1da06953b3d1b600cd8cbbab5f60b</guid>
				<title>Garner Jonassen posted an update: Cancer patient blood samples containing soluble human [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26806/</link>
				<pubDate>Wed, 11 Jun 2025 08:50:31 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cancer patient blood samples containing soluble human programmed cell death-ligand 1 (shPD-L1) have been observed to correlate negatively with the projected course of the disease. Furthermore, the detailed mechanisms connecting elevated shPD-L1 levels to disease advancement remain obscure, and substantial information gaps exist.</p>
<p>This&hellip;<span class="activity-read-more" id="activity-read-more-26806"><a href="https://www.catswannabecats.com/activity/p/26806/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">664cd8af58e62fe7e1876109e84fa617</guid>
				<title>Garner Jonassen posted an update: Cancer patient blood samples containing soluble human [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26800/</link>
				<pubDate>Wed, 11 Jun 2025 08:38:38 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cancer patient blood samples containing soluble human programmed cell death-ligand 1 (shPD-L1) have been observed to correlate negatively with the projected course of the disease. Furthermore, the detailed mechanisms connecting elevated shPD-L1 levels to disease advancement remain obscure, and substantial information gaps exist.</p>
<p>This&hellip;<span class="activity-read-more" id="activity-read-more-26800"><a href="https://www.catswannabecats.com/activity/p/26800/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8c1e39c89b4e68d6dd94c3fb1d2bf036</guid>
				<title>Garner Jonassen posted an update: Pretreatment induced partial decomposition of the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/13872/</link>
				<pubDate>Sun, 01 Jun 2025 23:37:12 -0400</pubDate>

									<content:encoded><![CDATA[<p>Pretreatment induced partial decomposition of the Mn02Zr08O2- solid solution, which fostered the development of surface areas enriched with Mn, showcasing catalytic activity in the oxidation of CO. The results of this study highlight that the introduction of oxidation-reduction pretreatment cycles causes an enhancement in catalytic activity, due&hellip;<span class="activity-read-more" id="activity-read-more-13872"><a href="https://www.catswannabecats.com/activity/p/13872/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c4a84c0a8d89d609f1e7d225e9cc82aa</guid>
				<title>Garner Jonassen became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/13791/</link>
				<pubDate>Sun, 01 Jun 2025 22:14:57 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>